Related Experiment Video
Updated: Jul 18, 2026
04:59
Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases
Published on: June 20, 2025
Endothelial progenitor cells and abdominal aortic aneurysms.
Joe Dawson1, Jenny Tooze, Gillian Cockerill
1Department of Vascular Surgery, St. George's Hospital and St. George's, University of London, London, UK.
Annals of the New York Academy of Sciences
|December 22, 2006
Summary
Patients with abdominal aortic aneurysms (AAA) have significantly higher levels of circulating endothelial progenitor cells (EPCs) compared to healthy individuals. Further research is needed to understand the role of these stem cells in AAA development and progression.
Area of Science:
- Vascular Biology
- Regenerative Medicine
- Stem Cell Research
Background:
- Endothelial progenitor cells (EPCs) are crucial circulating stem cells that repair vascular damage.
- Abdominal aortic aneurysm (AAA) is a serious vascular condition characterized by aortic wall weakening.
Purpose of the Study:
- To quantify the levels of EPCs in patients diagnosed with AAA.
- To compare EPC levels in AAA patients against age-matched healthy controls.
Main Methods:
- Immunomagnetic selection of CD133(+) peripheral blood mononuclear cells.
- Flow cytometry analysis using CD34/CD133 as EPC markers.
- Comparison of EPC percentages between AAA patients and controls.
Main Results:
- AAA patients exhibited significantly elevated circulating EPC levels (2.43%) compared to controls (1.25%, P = 0.008).
- The study successfully enumerated EPCs in the peripheral blood of AAA patients.
Conclusions:
- Circulating EPC levels are higher in patients with abdominal aortic aneurysms.
- The precise function of EPCs in AAA pathogenesis requires further investigation, possibly involving angiogenesis.
More Related Videos
Related Concept Videos
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:30Aneurysm I: Introduction
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
01:26Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...